Skip to main content

Day: June 5, 2025

Richemont publishes FY25 Annual Report and Non-Financial Report

5 JUNE 2025  RICHEMONT PUBLISHES FY25 ANNUAL REPORT AND NON-FINANCIAL REPORT Richemont has today published its combined Annual Report and Accounts with the Business review, the Compensation Report and the Corporate Governance Report, along with its Non-Financial Report, for the year ended 31 March 2025. The Annual Report and Accounts, which includes the Chairman’s review to shareholders, the annual consolidated and statutory financial statements, and the corresponding audit reports was already published on 16 May 2025. The Non-Financial Report 2025, prepared in accordance with the Global Reporting Initiative (GRI) Standards (2021), provides Richemont’s disclosures on non-financial matters. The report complies with the reporting disclosure required by Articles 964a-c of the Swiss Code of Obligations, including the Swiss Ordinance...

Continue reading

Ageas Re partners with Slovenian insurer Triglav Group in connection with the Motor insurance business distributed by Italian Insurtech Prima

Ageas Re partners with Slovenian insurer Triglav Group in connection with the Motor insurance business distributed by Italian Insurtech Prima Today, Ageas Re, the reinsurance arm of Ageas Group, concluded a reinsurance agreement with Slovenian insurer Triglav Group in connection with the partnership entered into by Triglav Group with leading Italian direct Motor insurance distributor, Prima Assicurazioni S.p.A. (Prima), with the objective to expand its business portfolio and to contribute to the Ageas’s Elevate27 profitable growth ambitions. Under to the agreement, Ageas Re takes an 80% Quota Share on the Prima business underwritten by Triglav Group in 2025, commencing in the coming weeks. Prima is a rapidly growing, profitable insurance distributor that began distributing personal lines policies, mainly Motor, in 2015. Since then, it...

Continue reading

EssilorLuxottica signs an agreement to acquire A-Look, Seen and OWL retail stores in Malaysia

EssilorLuxottica signs an agreement to acquireA-Look, Seen and OWL retail stores in Malaysia With this transaction, the Group aims at further elevating the standards of vision care in the country Paris, France (5 June 2025) – EssilorLuxottica announces today it has signed an agreement for the acquisition of one of the largest optical companies in Malaysia operating over 90 stores under the A-Look, Seen and OWL banners. A-Look was founded in 2003 by Dato Terry Ngeow, with the opening of its inaugural store in Kuala Lumpur, Malaysia. At present, A-Look, Seen and OWL stores are located across East and West (or Peninsular) Malaysia. With the acquisition of these renowned omnichannel and multi-branded stores, EssilorLuxottica aims at complementing its long-standing position in Malaysia, where the Group is currently present with both wholesale...

Continue reading

IDEX Biometrics ASA: Last day of the subscription period in the subsequent offering

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 21 May 2025 regarding the subscription period (the “Subscription Period”) in the subsequent offering (the “Subsequent Offering”) consisting of up to 600 million new shares at a subscription price of NOK 0.01 per share (“Offer Shares”). The Subscription Period will end today, 5 June 2025, at 16:30 CET. This Subsequent Offering is conducted to give the shareholders not participating in the debt conversion on 11 April 2025 an opportunity to subscribe for Offer Shares at a subscription price per share equal to the subscription price in the debt conversion. Completed subscription forms must be received by Arctic Securities AS, or, in the case of online subscriptions, be registered by the expiry of the Subscription Period. Subscription rights that...

Continue reading

[Valneva SE] Declaration of shares and voting rights – May 2025

VALNEVA Declaration of shares and voting rights May 31, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris – Compartment B Declaration date: June 5, 2025Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**  170,188,190 ordinary shares with a par value of €0.15 each 186,313,236 Double voting rights granted on 236,308 ordinary shares   Capital increase without preferential subscription rights (2,916,666 new ordinary...

Continue reading

VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION

Press Release VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION Meudon (France), June 5, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the official qualification of Delphy, its vertical gaseous hydrogen storage solution, by DNV. A world first, Delphy enables the storage of 1 to 100 tons of hydrogen under maximum safety conditions. Thanks to its minimal footprint, this vertical system – extending up to 100 meters underground – meets the challenge of complex and demanding industrial environments. It targets both green hydrogen producers and industrial players such as synthetic fuel producers (e-SAF, e-methanol), green ammonia producers, steelmakers, and refineries. The Delphy solution is the result of Vallourec’s longstanding expertise...

Continue reading

Planisware expands into Belgium to support the sustained growth of its business in the Benelux region

Planisware expands into Belgium to support the sustained growth of its business in the Benelux region Paris, France, June 5, 2025 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, continues its international expansion with the opening of a new office in Belgium. Planisware has been present in the Benelux region for several years, through projects carried out for leading clients such as Galapagos, KLM, Philips, and Engie, and is now consolidating its position in this strategic, fast-growing market. In particular, the Group has seen a sharp increase in its business in this market, with revenue doubling over the last four years, testifying to the relevance of its expertise and the confidence of its customers. This new location is primarily intended to strengthen proximity to Planisware’s customers...

Continue reading

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference 

Geneva, Switzerland, June 5, 2025 – Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that preclinical data from its gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) cough program will be presented at the 10th American Cough Conference (June 6-7) in Dulles, VA. A presentation given by Mikhail Kalinichev, Head of Translational Science at Addex will describe the progress seen to date with the Addex GABAB PAM cough program, including antitussive data from in vivo models. Addex lead drug candidate is ready to start IND enabling studies. Details of the Presentation Date:               Saturday, June 7, 2025Time:              11:20 am ESTTitle: ...

Continue reading

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea

Allschwil, Switzerland, June 05, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the sales threshold triggering the second USD 2.5 million milestone payment this year. David Veitch, Basilea’s Chief Executive Officer, stated: “This milestone payment for the Asia Pacific region, including China, reflects the strong and growing global demand for novel antifungal therapies. Continued growth of Cresemba, particularly in China, where uptake has been especially robust, reinforces its significant clinical value for patients...

Continue reading

MoneyHero and RCBC Forge Strategic Partnership to Tap into the Philippines’ Expanding Card Market

SINGAPORE, June 04, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced a strategic partnership with Rizal Commercial Banking Corporation (“RCBC”), a trusted leader in Philippine banking known for its customer-focused innovation and inclusive financial services, through its card servicing entity, RCBC Bankard Services Corporation (“RCBC Credit Cards”). Through this collaboration, MoneyHero will integrate RCBC’s full suite of rewards, lifestyle, travel, and premium credit card products into its digital platform, enabling Filipinos to seamlessly discover, compare, and apply for cards that suit their personal financial needs. This partnership...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.